keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
KALA, an amphiphilic peptide, adopts an α-helical conformation under physiological pH conditions. It functions as a fusogenic peptide, modifying the liposomal membrane that encapsulates plasmid DNA, thereby facilitating liver targeting and DNA transfection through galactose receptors.
Description | KALA, an amphiphilic peptide, adopts an α-helical conformation under physiological pH conditions. It functions as a fusogenic peptide, modifying the liposomal membrane that encapsulates plasmid DNA, thereby facilitating liver targeting and DNA transfection through galactose receptors. |
In vitro | Modifying a plasmid DNA-encapsulated liposomal membrane with KALA peptide enhances transgene expression and immune activation in bone marrow-derived dendritic cells (BMDCs)[1]. |
Molecular Weight | 3131.87 |
Formula | C144H248N40O35S |
CAS No. | 187987-64-0 |
keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
KALA 187987-64-0 inhibitor inhibit